Locoregional Treatment in Intrahepatic Cholangiocarcinoma: Which Treatment for Which Patient?

SIMPLE SUMMARY: Due to the rarity of the entity of cholangiocarcinoma, there is a lack of randomized clinical trials which can compared modalities of treatment for unresectable intra-hepatic cholangiocarcinoma (iCC). In this review, we proposed to summarize current evidence regarding all the modalit...

Descripción completa

Detalles Bibliográficos
Autores principales: Bourien, Héloïse, Pircher, Chiara Carlotta, Guiu, Boris, Lamarca, Angela, Valle, Juan W, Niger, Monica, Edeline, Julien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486617/
https://www.ncbi.nlm.nih.gov/pubmed/37686493
http://dx.doi.org/10.3390/cancers15174217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486617/
https://www.ncbi.nlm.nih.gov/pubmed/37686493
http://dx.doi.org/10.3390/cancers15174217

Ejemplares similares